Anvisa releases new medicine to treat malaria

Tafenoquine is an effective drug to fight the parasite Plasmodium vivax. The recent achievement may prevent relapses

New dengue vaccine performs well in large trials

Manufactured by pharmaceutical Takeda, overall, the drug was 80.2% effective

International consortium seeks development of new drugs for neglected diseases and malaria

Research and development of new drugs against neglected diseases and malaria will have investment of R$ 43,5 million. The purpose of the consortium is to identify preclinical candidates likely to become new drugs for the treatment of visceral leishmaniasis, Chagas disease and malaria

Piauí: Workshop contributes to strengthening Neglected Disease Care Networks

Lines of care refer to the organization of the population service, defining the flow from the smallest municipality to the highly complex service, thus ensuring effective and quality work

Interview

HPV in Acre: Misinformation causes rejection of vaccine by youngsters

Ministry of Health and University of São Paulo presented HPV vaccine evaluation

Brazilian Society of Tropical Medicine
Center for Tropical Medicine - UnB
Hours:
Monday to Friday from 8am to 12pm and from 14pm to 18pm
sbmt@sbmt.org.br - PO Box 4356 - Room 43C - 70904-970
Brasilia - DF - Phone/Fax: (61) 3307-1154

Chief-editor:
Carlos Henrique Nery Costa

Assignment editors:
Alberto Novaes
André Siqueira
Guilherme Werneck
Mitermayer Galvão dos Reis

Journalism:
Denise de Quadros
MTb 8458 DRT/RS

Translation:
Pedro Costa

Graphics and diagramation:
Leandro Matos